93 related articles for article (PubMed ID: 15661172)
1. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
[TBL] [Abstract][Full Text] [Related]
2. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
3. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
[TBL] [Abstract][Full Text] [Related]
4. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
Day JR; Van Damme N; Guatelli JC
Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
6. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
[TBL] [Abstract][Full Text] [Related]
7. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
8. The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.
Olivieri K; Scoggins RM; Bor YC; Matthews A; Mark D; Taylor JR; Chernauskas D; Hammarskjöld ML; Rekosh D; Camerini D
Virology; 2007 Feb; 358(1):23-38. PubMed ID: 16999983
[TBL] [Abstract][Full Text] [Related]
9. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection.
Singh SP; Tungaturthi P; Cartas M; Tomkowicz B; Rizvi TA; Khan SA; Kalyanaraman VS; Srinivasan A
Virology; 2001 Apr; 283(1):78-83. PubMed ID: 11312664
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of apoptosis induction by the HIV-1 envelope.
Perfettini JL; Castedo M; Roumier T; Andreau K; Nardacci R; Piacentini M; Kroemer G
Cell Death Differ; 2005 Aug; 12 Suppl 1():916-23. PubMed ID: 15719026
[TBL] [Abstract][Full Text] [Related]
13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
[TBL] [Abstract][Full Text] [Related]
16. CD4/CXCR4 co-expression allows productive HIV-1 infection in canine kidney MDCK cells.
Cervantes-Acosta G; Welman M; Freund F; Cohen EA; Lemay G
Virus Res; 2006 Sep; 120(1-2):138-45. PubMed ID: 16600413
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans.
Vidricaire G; Gauthier S; Tremblay MJ
J Infect Dis; 2007 May; 195(10):1461-71. PubMed ID: 17436226
[TBL] [Abstract][Full Text] [Related]
18. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
19. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
20. Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
Beauséjour Y; Tremblay MJ
Virology; 2004 Jun; 324(1):165-72. PubMed ID: 15183063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
